Cardiac Outcomes after Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance without Diabetes

BACKGROUND: Insulin resistance is highly prevalent among patients with atherosclerosis and is associated with an increased risk for myocardial infarction (MI) and stroke. The Insulin Resistance Intervention after Stroke (IRIS) trial demonstrated that pioglitazone decreased the composite risk for fat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circulation
Main Authors: Young, Lawrence H., Viscoli, Catherine M., Curtis, Jeptha P., Inzucchi, Silvio E., Schwartz, Gregory G., Lovejoy, Anne M., Furie, Karen L., Gorman, Mark J., Conwit, Robin, Abbott, J. Dawn, Jacoby, Daniel L., Kolansky, Daniel M., Pfau, Steven E., Ling, Frederick S., Kernan, Walter N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511545/
https://ncbi.nlm.nih.gov/pubmed/28246237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.116.024863
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados